13F HOLDINGS REPORT
Propel Bio Management, LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000898432-25-000357
Total Value
$86.1M
Positions
18
Other Managers
1
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PLAINS GP HOLDINGS LP-CL | PAGP | 1,272,360 | $27.2M | 31.57% |
| 2 | MADRIGAL PHARMACEUTICALS | MDGL | 30,032 | $9.9M | 11.56% |
| 3 | AKERO THERAPEUTICS INC | 00973Y108 | 228,884 | $9.3M | 10.76% |
| 4 | PHATHOM PHARMACEUTICALS I | PHAT | 1,134,927 | $7.1M | 8.27% |
| 5 | ACHIEVE LIFE SCIENCES INC | ACHV | 2,453,092 | $6.5M | 7.61% |
| 6 | APPLIED THERAPEUTICS INC | 03828A101 | 11,285,420 | $5.5M | 6.41% |
| 7 | AVIDITY BIOSCIENCES INC | 05370A108 | 178,500 | $5.3M | 6.12% |
| 8 | ABEONA THERAPEUTICS INC | ABEO | 624,022 | $3.0M | 3.45% |
| 9 | TSCAN THERAPEUTICS INC | TCRX | 2,087,139 | $2.9M | 3.35% |
| 10 | DELCATH SYSTEMS INC | DCTH | 177,600 | $2.3M | 2.63% |
| 11 | SYNDAX PHARMACEUTICALS IN | SNDX | 183,259 | $2.3M | 2.62% |
| 12 | ZEVRA THERAPEUTICS INC | ZVRA | 179,874 | $1.3M | 1.57% |
| 13 | MILESTONE PHARMACEUTICALS | MIST | 1,451,557 | $1.2M | 1.35% |
| 14 | MAAT PHARMA SACA | F5888J116 | 166,423 | $1.0M | 1.21% |
| 15 | COMPASS THERAPEUTICS INC | CMPX | 228,317 | $433,802 | 0.50% |
| 16 | ATHIRA PHARMA INC | 04746L104 | 1,492,792 | $425,296 | 0.49% |
| 17 | EIGER BIOPHARMACEUTICALS | 28249U204 | 146,381 | $423,000 | 0.49% |
| 18 | CHINOOK THERAPEUTICS | 169CVR016 | 79,357 | $38,500 | 0.04% |